ARYA Sciences Acquisition Corp II (ARYBU)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

222 JACOBS STREET CAMBRIDGE, MA 02141

ARYA Sciences Acquisition Corp II operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. ARYA Sciences Acquisition Corp II serves customers in the State of New York.

View SEC Filings from ARYBU instead.

View recent insider trading info

Funds Holding ARYBU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARYBU BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CEESAY ABRAHAM PRESIDENT

  • Officer
0 2021-05-03 1

COLES N ANTHONY PRESIDENT AND CEO

  • Officer
  • Director
0 2021-02-03 3

DIPIETRO KENNETH CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2021-02-03 2

YI KATHY CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-03 3

SANCHEZ RAMIRO CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-03 3

RENGER JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-03 3

BODENRADER MARK SEE REMARKS

  • Officer
0 2021-02-03 3

TREGONING KATHLEEN SEE REMARKS

  • Officer
0 2021-02-03 3

PATRICK DEVAL L

  • Director
0 2021-02-01 2

BARON DEBORAH

  • Director
0 2021-02-01 2

MISHAN ORLY CHIEF BUSINESS OFFICER

  • Officer
38,450 2021-01-25 2

RIEDEL NORBERT G

  • Director
28,540 2021-01-04 2

MCKERNAN RUTH

  • Director
0 2021-01-04 2

BAIN CAPITAL INVESTORS LLC

BC PERCEPTION HOLDINGS, LP

BCPE PERCEPTION GP, LLC

BAIN CAPITAL FUND XII, LP

BAIN CAPITAL PARTNERS XII, LLC

  • 10% Owner
60,632,356 2020-11-09 3

GORDON CHRISTOPHER R

  • Director
  • 10% Owner
60,632,356 2020-11-09 3

KOPPEL ADAM

  • Director
  • 10% Owner
60,632,356 2020-11-09 3

PFIZER INC

  • 10% Owner
26,149,211 2020-10-27 2

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • Director
No longer subject to file 2020-10-27 3

DEKKERS MARIJN E

  • Director
28,540 2020-10-27 1

SULZBERGER GABRIELLE

  • Director
14,270 2020-10-27 1

PHILLIPS BRYAN K CHIEF LEGAL OFFICER

  • Officer
0 2020-10-27 1

GIORDANO DOUGLAS E.

  • Director
0 2020-10-27 1

BIRNBAUM MORRIS

  • Director
0 2020-10-27 1

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • Director
0 2020-10-20 3

STONE ADAM LEO CHIEF EXECUTIVE OFFICER

499,000 2020-06-09 0

ALTMAN MICHAEL SETH CHIEF FINANCIAL OFFICER

499,000 2020-06-09 0

ARYA SCIENCES HOLDINGS II

499,000 2020-06-09 0

EDELMAN JOSEPH

0 2020-06-04 0

WIDER TODD

0 2020-06-04 0

BAUER JAKE

0 2020-06-04 0

POUKALOV KONSTANTIN CHIEF BUSINESS OFFICER

0 2020-06-04 0

ROBINS CHAD M

0 2020-06-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments